Stephen Orena Selected Research

(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acid

1/2013

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Orena Research Topics

Disease

2	Malaria 01/2022 - 01/2021
1	Neuroblastoma 09/2015
1	Fibrosis (Cirrhosis) 01/2013
1	Hyperkalemia 01/2013

Drug/Important Bio-Agent (IBA)

1	Pyrimethamine (Daraprim)FDA Link 01/2022
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 01/2022
1	Proguanil (Paludrine)FDA Link 01/2022
1	cycloguanilIBA 01/2022
1	ArtemisininsIBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	Firefly LuciferasesIBA 09/2015
1	(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acidIBA 01/2013
1	Eplerenone (Inspra)FDA LinkGeneric 01/2013
1	AldosteroneIBA 01/2013
1	Mineralocorticoid Receptor AntagonistsIBA 01/2013
1	CollagenIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013

Therapy/Procedure

1	Chemoprevention 01/2022
1	Therapeutics 01/2021